The relationship between cholesteryl ester transfer protein and cardiovascular risk.
Barter
Philip J
PJ
The Heart Research Institute, Sydney, Australia. barterp@hri.org.au
D000818:Animals; D000924:Anticholesteremic Agents / Q000009:adverse effects; D050197:Atherosclerosis / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors / Q000097:blood* / Q000235:genetics; D020022:Genetic Predisposition to Disease; D006801:Humans; D011110:Polymorphism, Genetic; D011804:Quinolines / Q000009:adverse effects; D012306:Risk
D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D011804:Quinolines; C483909:torcetrapib